SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 63 filers reported holding SIERRA ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $23,000 | -90.4% | 41,076 | -70.7% | 0.00% | -89.7% |
Q1 2019 | $240,000 | -30.0% | 140,376 | -30.4% | 0.03% | -38.3% |
Q4 2018 | $343,000 | 0.0% | 201,660 | 0.0% | 0.05% | +30.6% |
Q3 2018 | $343,000 | -42.5% | 201,660 | 0.0% | 0.04% | -46.3% |
Q2 2018 | $597,000 | +43.2% | 201,660 | 0.0% | 0.07% | +45.7% |
Q1 2018 | $417,000 | -44.5% | 201,660 | 0.0% | 0.05% | -51.1% |
Q4 2017 | $752,000 | +140.3% | 201,660 | 0.0% | 0.09% | +135.0% |
Q3 2017 | $313,000 | +32.6% | 201,660 | 0.0% | 0.04% | +53.8% |
Q2 2017 | $236,000 | -23.6% | 201,660 | 0.0% | 0.03% | -27.8% |
Q1 2017 | $309,000 | – | 201,660 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 8,112,121 | $12,412,000 | 6.63% |
New Leaf Venture Partners, L.L.C. | 2,592,593 | $3,967,000 | 2.03% |
Vivo Capital, LLC | 2,438,270 | $3,731,000 | 1.10% |
DAFNA Capital Management LLC | 265,000 | $405,000 | 0.34% |
Perceptive Advisors | 3,703,704 | $5,667,000 | 0.32% |
NEXTHERA CAPITAL LP | 400,000 | $612,000 | 0.31% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,972,319 | $7,608,000 | 0.29% |
SABBY MANAGEMENT, LLC | 1,746,261 | $2,672,000 | 0.14% |
VHCP Management II, LLC | 130,798 | $200,000 | 0.08% |
Orbimed Advisors | 3,703,704 | $5,667,000 | 0.06% |